Skip to main content

Cardiff Oncology, Inc.

For the period ended Sep 30, 2026. Filed Nov 12, 2026.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Sep 30, 2026 · Filed Nov 12, 2026

CRDF$0.73-4.9%Stored close · as of Nov 12, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Item 6. Exhibits

Checking your notes…

ExhibitNumberDescription of Exhibit
3.1Certificate of Amendment to Amended and Restated Certificate of Incorporation of Cardiff Oncology, Inc. (incorporated by reference to Exhibit 3.1 to Form 8-K filed on October 27, 2026)
10.1Amendment to License Agreement, dated as of September 14, 2026 by and between Cardiff Oncology, Inc. and Nerviano Medical Sciences S.r.l* (incorporated by reference to Exhibit 10.1 to Form 8-K filed on September 14, 2026)
10.2Amended and Restated Consulting Agreement between Cardiff Oncology, Inc. and Leila Alland Md Consultancy LLC dated October 23, 2026.
31.1Certification of Principal Executive Officer required by Rule 13a-14(a)/15d-14(a) under the Exchange Act.
31.2Certification of Principal Financial Officer required by Rule 13a-14(a)/15d-14(a) under the Exchange Act.
32.1Certification of Principal Executive Officer pursuant to 18 U.S.C Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
32.2Certification of Principal Financial Officer pursuant to 18 U.S.C Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
101.INSInline XBRL Instance Document – the instance document does not appear in the Interactive Data File because XBRL tags are embedded within the Inline XBRL document.
101.SCHInline XBRL Taxonomy Extension Schema With Embedded Linkbase Documents
104Cover Page Interactive Data File (embedded within the Inline XBRL document)
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.